Cowen and Company’s MDxHealth MDXH Stock Holding History

Cowen and Company’s Portfolio MDXH Stock Details MDXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-135,090	Closed	-$281K	–	191
2024 Q3	$281K	Buy	+135,090	New	+$367K	0.01%	211

Other funds holding MDXH

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cowen and Company's MDXH Position: Q4 2024 in Review

Cowen and Company sold out of MDxHealth (MDXH) in Q4 2024, closing a stake of 135,090 shares — an estimated $281K sold.

Cowen and Company first reported a position in MDXH in Q3 2024 and held it in 1 quarter. The position peaked at $281K in Q3 2024. 24 funds tracked by Wall St. Rank hold MDXH as of Q4 2024.

Cowen and Company reported no remaining MDxHealth position as of Q4 2024 after selling out during the quarter.
Cowen and Company sold 135,090 MDxHealth shares in Q4 2024, an estimated $281K.
Cowen and Company first reported a position in MDxHealth in Q3 2024 and held it in 1 quarter.
Cowen and Company's MDxHealth position peaked at $281K in Q3 2024.
24 funds tracked by Wall St. Rank held MDxHealth as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.